Real-world evidence is only as strong as the data underpinning it — and misclassification of cases, exposures, and outcomes remains one of the most persistent and underappreciated challenges in RWE.
This paper delivers a practical, fit-for-purpose playbook for researchers and study teams navigating this complexity. It covers the full validation workflow: from constructing defensible algorithms grounded in clinical reality, to establishing a “gold standard” reference standard, to selecting the right operational approach — whether patient profile review or full medical chart review — proportionate to the stakes of the study.
The paper also tackles the harder questions: how to handle algorithm transportability across geographies, how to choose between positive predictive value (PPV)-focused vs. fully labeled validation designs, and when iterative data-driven refinement (including ML/AI) adds genuine value vs. creates a ‘black box’ not suitable for all use cases.
Validation doesn’t eliminate the imperfections of routine data, but it makes uncertainty explicit, quantifies misclassification, and converts messy RWD into evidence that can be defended in front of regulators, payers, and clinical audiences.
If you’re designing or commissioning RWE studies where the stakes are high, this is required reading.
Complete the form to access the full whitepaper
"*" indicates required fields